Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Tenascin-C, GLUT-1, and syndecan-2 expression in juvenile nasopharyngeal angiofibroma: correlations to vessel density and tumor stage.

Renkonen S, Heikkilä P, Haglund C, Mäkitie AA, Hagström J.

Head Neck. 2013 Jul;35(7):1036-42. doi: 10.1002/hed.23083.

PMID:
22791513
2.

The presence of tumor-infiltrating IL-17-producing cells in juvenile nasopharyngeal angiofibroma tumor microenvironment is a poor prognostic factor.

Sun X, Guo L, Wang H, Yu H, Wang J, Meng X, Liu Z, Liu J, Hu L, Li H, Wang D.

Am J Otolaryngol. 2014 Sep-Oct;35(5):582-8. doi: 10.1016/j.amjoto.2014.06.001.

PMID:
25014998
3.

Stem cell-related proteins C-KIT, C-MYC and BMI-1 in juvenile nasopharyngeal angiofibroma--do they have a role?

Renkonen S, Häyry V, Heikkilä P, Leivo I, Haglund C, Mäkitie AA, Hagström J.

Virchows Arch. 2011 Feb;458(2):189-95. doi: 10.1007/s00428-010-1010-9.

PMID:
21113618
4.

Vessel density, proliferation, and immunolocalization of vascular endothelial growth factor in juvenile nasopharyngeal angiofibromas.

Brieger J, Wierzbicka M, Sokolov M, Roth Y, Szyfter W, Mann WJ.

Arch Otolaryngol Head Neck Surg. 2004 Jun;130(6):727-31.

PMID:
15210553
5.

Biological distinctions between juvenile nasopharyngeal angiofibroma and vascular malformation: an immunohistochemical study.

Zhang M, Sun X, Yu H, Hu L, Wang D.

Acta Histochem. 2011 Oct;113(6):626-30. doi: 10.1016/j.acthis.2010.07.003.

PMID:
20688360
6.

Toll-like receptors 3, 7, and 9 in Juvenile nasopharyngeal angiofibroma.

Renkonen S, Cardell LO, Mattila P, Lundberg M, Haglund C, Hagström J, Mäkitie AA.

APMIS. 2015 May;123(5):439-44. doi: 10.1111/apm.12366.

PMID:
25912131
7.

Proliferation, angiogenesis and hormonal markers in juvenile nasopharyngeal angiofibroma.

Saylam G, Yücel OT, Sungur A, Onerci M.

Int J Pediatr Otorhinolaryngol. 2006 Feb;70(2):227-34.

PMID:
16023739
8.

Endoglin (CD105) expression on microvessel endothelial cells in juvenile nasopharyngeal angiofibroma: tissue microarray analysis and association with prognostic significance.

Wang JJ, Sun XC, Hu L, Liu ZF, Yu HP, Li H, Wang SY, Wang DH.

Head Neck. 2013 Dec;35(12):1719-25. doi: 10.1002/hed.23210.

PMID:
23471755
9.

Immunohistochemical analysis of growth mechanisms in juvenile nasopharyngeal angiofibroma.

Schuon R, Brieger J, Heinrich UR, Roth Y, Szyfter W, Mann WJ.

Eur Arch Otorhinolaryngol. 2007 Apr;264(4):389-94.

PMID:
17177025
10.

Hormonal receptors and vascular endothelial growth factor in juvenile nasopharyngeal angiofibroma: immunohistochemical and tissue microarray analysis.

Liu Z, Wang J, Wang H, Wang D, Hu L, Liu Q, Sun X.

Acta Otolaryngol. 2015 Jan;135(1):51-7. doi: 10.3109/00016489.2014.952774.

PMID:
25384380
11.

Immunolocalization of activated transforming growth factor beta1 in juvenile nasopharyngeal angiofibroma.

Dillard DG, Cohen C, Muller S, Del Gaudio J, Reichman O, Parrish B, Rackley D, Gal AA.

Arch Otolaryngol Head Neck Surg. 2000 Jun;126(6):723-5.

PMID:
10864108
12.

Prognostic value of matrix metalloproteinase 9 expression in patients with juvenile nasopharyngeal angiofibroma: tissue microarray analysis.

Sun X, Guo L, Wang J, Wang H, Liu Z, Liu J, Yu H, Hu L, Li H, Wang D.

Int J Pediatr Otorhinolaryngol. 2014 Aug;78(8):1232-8. doi: 10.1016/j.ijporl.2014.04.003.

PMID:
24969348
13.

[Expression of PCNA, VEGF and bFGF in endothelial cells of juvenile nasopharyngeal angiofibroma].

Sun Y, Wu Z.

Lin Chuang Er Bi Yan Hou Ke Za Zhi. 2006 Dec;20(23):1076-8. Chinese.

PMID:
17285972
14.

Staging and surgical approaches in large juvenile angiofibroma--study of 95 cases.

Tyagi I, Syal R, Goyal A.

Int J Pediatr Otorhinolaryngol. 2006 Sep;70(9):1619-27.

PMID:
16777240
15.

[Significance of heparanase, bFGF and VEGF in angiogenesis for nasopharyngeal angiofibroma outspreading].

Wang J, Yi Z, Zhao D, Chen M, Li Z.

Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2011 Nov;25(21):970-3, 976. Chinese.

PMID:
22260074
16.

Wnt pathway, angiogenetic and hormonal markers in sporadic and familial adenomatous polyposis-associated juvenile nasopharyngeal angiofibromas (JNA).

Ponti G, Losi L, Pellacani G, Rossi GB, Presutti L, Mattioli F, Villari D, Wannesson L, Alicandri Ciufelli M, Izzo P, De Rosa M, Marone P, Seidenari S.

Appl Immunohistochem Mol Morphol. 2008 Mar;16(2):173-8. doi: 10.1097/PAI.0b013e31806bee12.

PMID:
18227724
17.

Systems-level analysis of clinically different phenotypes of juvenile nasopharyngeal angiofibromas.

Renkonen S, Kankainen M, Hagström J, Haglund C, Monni O, Mäkitie AA.

Laryngoscope. 2012 Dec;122(12):2728-35. doi: 10.1002/lary.23592.

PMID:
22965421
18.

Exclusively endoscopic surgery for juvenile nasopharyngeal angiofibroma.

Andrade NA, Pinto JA, Nóbrega Mde O, Aguiar JE, Aguiar TF, Vinhaes ES.

Otolaryngol Head Neck Surg. 2007 Sep;137(3):492-6.

PMID:
17765782
19.

Nasopharyngeal angiofibroma with intracellular accumulation of SPARC - a hypothesis (SPARC in nasopharyngeal angiofibroma).

Krstulja M, Car A, Bonifacić D, Braut T, Kujundzić M.

Med Hypotheses. 2008;70(3):600-4.

PMID:
17681430
20.

Juvenile nasopharyngeal angiofibroma: an immunohistochemical characterisation of the stromal cell.

Pauli J, Gundelach R, Vanelli-Rees A, Rees G, Campbell C, Dubey S, Perry C.

Pathology. 2008 Jun;40(4):396-400. doi: 10.1080/00313020802035857.

PMID:
18446631
Items per page

Supplemental Content

Support Center